Skip to main navigation Skip to search Skip to main content

A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3)

  • T.S. Waddell
  • , I. Chau
  • , Y. Barbachano
  • , D.G. de Castro
  • , A. Wotherspoon
  • , C. Saffery
  • , G.W. Middleton
  • , J. Wadsley
  • , D.R. Ferry
  • , W. Mansoor
  • , T.D.L. Crosby
  • , F.Y. Coxon
  • , D. Smith
  • , J.S. Waters
  • , T. Iveson
  • , S. Falk
  • , S. Slater
  • , A.F.C. Okines
  • , D. Cunningham

Research output: Contribution to conferenceOther contribution to conferencepeer-review

Original languageEnglish
Publication statusPublished - 20 Jun 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this